fda tirzepatide announcement update on FDA has announced that the shortage of # tirzepatide, the ingredient in Lilly's US judge sides with FDA's
Description
However, compounded tirzepatide generally costs significantly less than brand-name Mounjaro, which lists at approximately $1,000 to $1,200 per month without insurance coverage

When it works more slowly, weight loss also slows down
The concerns are transparency and pharmacy handling
Schedule: First injection timed so that days 2 and 3 fall on low-obligation days

10.1111/dom.16275
Zepbound is indicated for adults with obesity (with a BMI of 30 kg/m 2 or greater), or those who are overweight (with a BMI of 27 kg/m 2 or greater) and also have weight-related medical problems such as hypertension, dyslipidemia, type 2 diabetes mellitus, obstructive sleep apnea or cardiovascular disease, to lose weight and keep it off